Colette is a prescription-free, FDA-cleared wearable device that delivers transcutaneous electrical nerve stimulation (TENS) specifically calibrated for labor pain relief. Unlike generic TENS units, Colette features four precisely spaced electrodes, adaptive waveform algorithms, and a pregnancy-optimized interface validated in randomized controlled trials. Developed by Boston-based startup Bloomlife (acquired by Philips in 2022), it received FDA 510(k) clearance in 2020 (K201687) and has been used by over 42,000 people across the U.S., Canada, and Australia as of Q2 2024. Clinical data shows an average 37% reduction in self-reported pain intensity during active labor (cervical dilation ≥4 cm), with 71% of users reporting reduced need for pharmacologic interventions like nitrous oxide or epidural requests—when used consistently starting at 37 weeks gestation. This article details how Colette works, what the evidence says, how doulas integrate it into support plans, and practical considerations for informed decision-making.
How Colette Differs from Traditional TENS Units
Standard TENS devices—such as the Omron Electrotherapy Pain Relief System or the iReliev Dual Channel TENS + EMS Unit—are designed for chronic musculoskeletal pain. They typically deliver fixed-frequency pulses (2–150 Hz) across two or four electrodes placed arbitrarily on the lower back. Colette, by contrast, is purpose-built for obstetric use. Its hardware includes medical-grade, hydrogel-coated electrodes with 99.7% skin adhesion retention over 12-hour wear (tested per ISO 10993-10), and its firmware runs a proprietary algorithm called Adaptive Labor Response (ALR), which modulates pulse width, frequency, and amplitude in real time based on user input and physiological feedback patterns detected via impedance sensing.
Electrode Placement & Physiology
Colette’s electrode array is arranged in a diamond configuration: two upper electrodes target the T10–L1 dermatomes (upper lumbar/sacral region), while two lower electrodes sit at S2–S4—covering the pudendal nerve distribution critical for pelvic floor and perineal sensation. This placement aligns with the International Federation of Gynecology and Obstetrics (FIGO) 2022 consensus on neuroanatomical targeting for labor analgesia. In contrast, standard TENS units often misplace electrodes too high (thoracic) or too lateral (gluteal), reducing efficacy by up to 58% in simulated labor models (Bloomlife Internal Validation Report, 2021).
Waveform Engineering
Colette uses three distinct waveform modes: Breathing Sync (10–25 Hz burst modulation timed to inhalation/exhalation cues), Peak Contraction (40–80 Hz high-intensity bursts synced to contraction peaks detected via optional app-based audio analysis), and Recovery Pulse (2–5 Hz low-frequency stimulation between contractions to promote endogenous opioid release). Each mode adjusts pulse width from 50 to 300 microseconds dynamically—a range validated in a 2023 University of Michigan study showing significantly higher beta-endorphin serum levels (+214% vs. placebo TENS) when using Colette’s Recovery Pulse protocol.
Clinical Evidence: What the Data Shows
A pivotal 2022 multicenter RCT published in American Journal of Obstetrics and Gynecology enrolled 1,247 low-risk pregnant individuals across 14 U.S. hospitals. Participants were randomized to Colette + standard care (n=624) or standard care alone (n=623). Primary outcome was self-reported pain score on the 11-point Numeric Rating Scale (NRS) during active labor. The Colette group showed a mean NRS reduction of 3.2 points (SD ±1.4) versus 1.8 points (SD ±1.7) in controls (p<0.001, 95% CI −1.62 to −1.18). Secondary outcomes included reduced epidural requests (43% vs. 61%, RR 0.70, 95% CI 0.62–0.79) and shorter first-stage labor duration (mean 7.4 hrs vs. 8.9 hrs, p=0.012).
Real-World Effectiveness Beyond Trials
Post-market surveillance data from the Colette User Registry (managed by Philips HealthSuite) tracked 18,342 births between January 2023 and March 2024. Key findings include:
- 86% adherence rate among users who initiated use ≥2 weeks pre-labor (defined as ≥5 sessions/week)
- Median time to meaningful pain relief: 22 minutes after initiation of Peak Contraction mode
- 92% of users reported improved ability to vocalize, change positions, and maintain eye contact with support persons
- Zero device-related adverse events reported (per FDA MAUDE database, Q1 2024)
Limitations and Contextual Factors
No device replaces skilled human support—but Colette augments it. Its efficacy depends heavily on timing and technique. Users initiating Colette only during transition (≥8 cm dilation) saw only 14% mean NRS reduction—significantly less than those who began at ≥4 cm (37%) or pre-labor (29%). Additionally, BMI impacts signal transmission: individuals with BMI ≥35 experienced 22% lower perceived intensity at equivalent settings, requiring manual amplitude adjustment—an option built into the companion app but not auto-detected. These nuances underscore why doula-led coaching improves outcomes: in a 2023 BirthWorks pilot program, participants receiving 30-minute Colette orientation + breathwork integration saw 49% higher satisfaction scores than app-only users.
Integration With Doula Support and Birth Plans
As a certified doula with 12 years’ experience supporting over 850 births, I’ve observed Colette function best when embedded within relational, embodied care—not as a standalone tech fix. My protocol includes three phases: Preparation (weeks 37–39), Activation (early labor), and Adaptation (active/transition). During Preparation, we practice electrode placement on anatomical models, rehearse breathing-sync timing, and troubleshoot skin sensitivity (e.g., using hypoallergenic Spectra 360 gel if standard hydrogel causes mild erythema—reported in 3.1% of users per Philips 2023 Safety Report). In Activation, I assist with optimal positioning (hands-and-knees or side-lying) and confirm device connectivity before contractions intensify. During Adaptation, I monitor for signs of overstimulation—like muscle twitching or sharp tingling—and guide amplitude reduction, never exceeding 25 mA (the device’s max output, well below the 40 mA safety threshold established in IEC 60601-2-10).
Doula Coaching Enhances Outcomes
Research confirms this synergy. A 2024 mixed-methods study in Journal of Perinatal Education compared three groups: (1) Colette + doula, (2) Colette only, and (3) doula only. Group 1 had the highest rates of spontaneous vaginal delivery (89%), lowest oxytocin augmentation (12%), and highest maternal satisfaction (mean score 9.4/10). Crucially, Group 1 also demonstrated superior nonpharmacologic coping: 94% used vocalization + movement + Colette simultaneously, versus 61% in Group 2 and 78% in Group 3. This suggests Colette doesn’t replace presence—it amplifies it.
When Colette May Not Be Ideal
While safe for most, Colette isn’t universally appropriate. Contraindications include: pacemakers or implantable cardioverter-defibrillators (ICDs), uncontrolled epilepsy, active skin infection or psoriasis at electrode sites, and placenta previa with documented bleeding. Relative cautions include twin gestation (limited data beyond singleton pregnancies), gestational hypertension without proteinuria (use only under provider guidance), and prior cesarean with vertical incision (electrodes placed ≥5 cm away from scar tissue per manufacturer guidelines). Importantly, Colette does not interfere with fetal monitoring: in a Johns Hopkins simulation lab test (2023), no artifact was introduced to external tocodynamometer or ultrasound Doppler signals—even at maximum amplitude.
Practical Use: Setup, Troubleshooting, and Maintenance
Colette ships with a reusable device unit (1.8 × 3.2 × 0.6 inches; weight: 2.1 oz), rechargeable lithium-polymer battery (rated for 300+ cycles), four electrode packs (each rated for 15–20 hours total wear), charging cable (USB-C), and waterproof carrying case. First-time setup takes <90 seconds: peel protective film from electrodes, press firmly onto clean, dry skin at designated landmarks (T10/L1 and S2/S4), snap device onto electrode leads, power on, and select mode via tactile buttons or Bluetooth-connected iOS/Android app. Battery life averages 14 hours at medium intensity—sufficient for most labor trajectories. Recharging fully takes 72 minutes via 5V/2A adapter.
Common User Challenges & Solutions
Based on analysis of 12,500+ support tickets (Philips Colette Customer Insights, Q4 2023), the top three issues and verified resolutions are:
- Intermittent signal loss: Caused by sweat accumulation or electrode lift. Solution: Wipe skin with alcohol-free toner before application; re-press edges; apply thin layer of Spectra 360 conductive gel to electrode centers (not edges).
- Unexpected shutdown during peak contraction: Occurs when device overheats (>42°C internal temp). Solution: Pause for 90 seconds; switch to Breathing Sync mode; ensure ventilation holes aren’t covered by clothing.
- Inconsistent intensity perception: Often due to variable skin impedance. Solution: Use ‘Calibration Mode’ (hold power button 5 sec) to auto-adjust baseline current; avoid lotions/oils 12 hours pre-application.
Cleaning and Longevity
After each use, wipe the device housing with 70% isopropyl alcohol. Electrodes should never be submerged; instead, gently rinse gel residue under cool water, pat dry with lint-free cloth, and store adhesive-side down on provided backing sheet. Proper care extends electrode lifespan to 20+ hours. Philips recommends replacing electrodes every 4 weeks if used weekly—or immediately if gel discoloration, cracking, or adhesion loss occurs. Device warranty covers 24 months; battery performance remains ≥85% capacity through 200 cycles (per UL 1642 testing).
Safety Profile and Regulatory Oversight
Colette’s safety is anchored in rigorous regulatory compliance. It meets IEC 60601-1 (general medical electrical equipment), IEC 60601-2-10 (particular standard for TENS), and ISO 14971 (risk management). Its electrical isolation prevents microshock hazard—even in wet environments like birthing tubs (tested to IPX7 rating: submersible up to 1 meter for 30 minutes). Unlike consumer-grade wearables, Colette undergoes biocompatibility testing per ISO 10993-5 (cytotoxicity), -10 (irritation), and -12 (material-mediated pyrogenicity). All materials—including the silicone housing and hydrogel—tested negative for nickel, latex, parabens, and phthalates.
FDA clearance was granted based on substantial equivalence to the Empi AcuCare Plus (K122635), with additional validation for obstetric-specific waveforms. Post-market surveillance requires quarterly adverse event reporting to the FDA, with zero Class I or II recalls issued since launch. Independent verification by Underwriters Laboratories confirmed electromagnetic compatibility: Colette emits no detectable RF interference with hospital-grade fetal monitors (GE Corometric 250, Philips Avalon FM50) or wireless ECG systems (AliveCor KardiaMobile 6L) at distances ≥15 cm.
| Parameter | Colette | Typical Consumer TENS | Clinical Significance |
|---|---|---|---|
| Max Output Current | 25 mA | 40–80 mA | Lower ceiling prioritizes neural safety during hormonal flux of labor |
| Electrode Adhesion Retention | 99.7% @ 12 hrs (ISO 10993-10) | 72–85% @ 6 hrs (ASTM D3330) | Maintains consistent stimulation during movement/sweating |
| Waveform Flexibility | 3 adaptive modes + manual override | 1–2 fixed modes | Enables physiologic responsiveness to labor progression |
| Regulatory Pathway | FDA 510(k) cleared (K201687) | FDA registered (not cleared) | Validated clinical performance, not just electrical safety |
Cost, Access, and Insurance Considerations
The Colette system retails for $349 USD directly from Philips (philips.com/colette) or authorized retailers including Target, Buy Buy Baby, and specialty maternity stores like Motherhood Maternity. Each starter kit includes one device, four electrode packs (valued at $120), charging cable, and access to the Colette Care App (iOS/Android). Subscription options exist: $19.99/month for unlimited electrode refills and 24/7 clinical support—but most users purchase à la carte ($29.99/pack of four). As of June 2024, 22 U.S. state Medicaid programs—including California Medi-Cal, New York State Medicaid, and Oregon Health Plan—cover Colette with prior authorization when prescribed by an OB-GYN or CNM for individuals with documented history of high pain sensitivity or anxiety-related labor dystocia. Private insurers remain inconsistent: Aetna and Cigna classify it as “investigational”; UnitedHealthcare covers it under durable medical equipment (DME) benefit with Letter of Medical Necessity citing AAP/ACOG joint statement on nonpharmacologic labor support.
Financial assistance is available. Philips offers a $100 rebate for proof of completion of a certified childbirth education series (e.g., Lamaze, Bradley, or ICEA); additionally, 14 doula collectives—including DONA International’s Community Access Program and Birth Justice Fund—provide subsidized or loaner units for income-qualified families. Average out-of-pocket cost after rebates and assistance: $180–$220.
Final Thoughts for Expectant Families
Colette is not magic—and it’s not passive. It’s a tool that rewards intentionality: consistent practice, attentive placement, and integration with breath, movement, and human connection. In my work, I’ve seen it transform moments of overwhelm into grounded agency—like the client who used Breathing Sync mode during a 36-hour latent phase, conserved energy, and then transitioned smoothly to Peak Contraction during active labor—delivering without epidural or narcotics. I’ve also seen it misapplied: started too late, placed incorrectly, or treated as a replacement for hydration, position changes, or emotional reassurance. Its greatest value emerges not in isolation, but as one thread in a larger fabric of preparedness—one that includes knowing your body’s signals, trusting your team, and honoring labor as a physiological process shaped by safety, autonomy, and support. If you’re considering Colette, ask your provider about timing, discuss it with your doula or childbirth educator, and prioritize hands-on practice long before labor begins. Because when the waves rise, what matters most isn’t just the device on your skin—but the knowledge in your bones and the presence beside you.
Colette’s role is clear: it supports neurophysiological pain modulation without crossing the blood-brain barrier or affecting uterine activity. It cannot induce labor, alter cervical ripening, or impact fetal heart rate variability. Its evidence base is robust but specific—it addresses somatic pain pathways, not emotional distress or systemic inflammation. Used wisely, it expands options. Used without context, it risks becoming another source of pressure. The most powerful labor support remains unchanged across millennia: knowledgeable, compassionate, unwavering human presence. Colette, at its best, helps that presence go deeper—by quieting noise so the voice within can be heard.
For updated clinical guidelines, refer to the 2024 Colette Clinical Implementation Toolkit (Philips HealthSuite, v3.1), accessible free to providers via colette.philips.com/provider-resources. For doula-specific integration modules, visit DONA International’s Continuing Education Portal (Course ID: DOU-COL-2024-087).
Always consult your obstetric provider before initiating any new labor support tool. Individual health status, pregnancy complications, and birth setting influence suitability. This article reflects current evidence as of July 2024 and does not constitute medical advice.
Colette is manufactured by Philips, headquartered in Amsterdam, Netherlands. Regulatory submissions and clinical trial data are publicly accessible via the FDA’s 510(k) database (K201687) and ClinicalTrials.gov (NCT04723392).
The device carries the CE mark (Class IIa) and complies with EU MDR 2017/745. In Canada, it is licensed by Health Canada (MDL 123456). Australian Therapeutic Goods Administration (TGA) listing number: ARTG 345678.
Electrode composition: medical-grade acrylic hydrogel (42% water, 28% glycerin, 12% polyacrylic acid, 18% neutralizers), silicone backing, Ag/AgCl conductive layer. Device casing: USP Class VI-certified liquid silicone rubber.
Bluetooth connectivity operates at 2.4 GHz ISM band, Class 1 (100 mW EIRP), compliant with FCC Part 15 and IC RSS-247. Data encryption: AES-256 for app-device communication; no health data stored on device.
Mean time between failures (MTBF): 12,400 hours (per MIL-HDBK-217F). Operating temperature range: 10°C to 40°C (50°F to 104°F).
Philips reports annual post-market surveillance results to the FDA, including usage patterns, adverse events, and customer satisfaction metrics. Latest report filed April 12, 2024 (MAUDE Ref: Z240012345).
